Cargando…

Clinical Effectiveness of Co-trimoxazole vs. Amoxicillin in the Treatment of Non-Severe Pneumonia in Children in India: A Randomized Controlled Trial

BACKGROUND: Acute respiratory infection (ARI) in young children is responsible for an estimated 4.1 million deaths worldwide of which approximately 90% are due to pneumonia. To study the clinical effectiveness of co-trimoxazole versus amoxicillin in the treatment of non-severe pneumonia, as defined...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rajesh, Shimoga Mahabala, Singhal, Vikram
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3843303/ https://www.ncbi.nlm.nih.gov/pubmed/24319556

Ejemplares similares

Quality of the Antibiotics—Amoxicillin and Co-Trimoxazole from Ghana, Nigeria, and the United Kingdom
por: Fadeyi, Ifeyinwa, et al.
Publicado: (2015)

Comparison of 3 Days Amoxicillin Versus 5 Days Co-Trimoxazole for Treatment of Fast-breathing Pneumonia by Community Health Workers in Children Aged 2–59 Months in Pakistan: A Cluster-randomized Trial
por: Sadruddin, Salim, et al.
Publicado: (2019)

Randomized trial of amoxicillin vs. placebo for pneumonia in Pakistan: A double blind community-based randomized trial of amoxicillin versus placebo for fast breathing pneumonia in children aged 2-59 months in Karachi, Pakistan (RETAPP)
por: Jehan, Fyezah, et al.
Publicado: (2020)

Comparison of the effect of co-trimoxazole and co-trimoxazole plus ciprofloxacin in urinary tract infection prophylaxis in kidney transplant patients
por: Khorvash, Farzin, et al.
Publicado: (2016)

Amoxicillin 3 vs 5 days for chest-indrawing pneumonia in Malawian children
por: Ginsburg, Amy Sarah, et al.
Publicado: (2020)

Genetic characterization of co-trimoxazole non-susceptible Streptococcus pneumoniae isolates from Indonesia
por: Safari, Dodi, et al.
Publicado: (2021)

Co-trimoxazole or multivitamin multimineral supplement for post-discharge outcomes after severe anaemia in African children: a randomised controlled trial
por: Maitland, Kathryn, et al.
Publicado: (2019)

A randomized controlled trial of hospital versus home based therapy with oral amoxicillin for severe pneumonia in children aged 3 – 59 months: The IndiaCLEN Severe Pneumonia Oral Therapy (ISPOT) Study
por: Patel, Archana B., et al.
Publicado: (2015)

Oral Amoxicillin Versus Benzyl Penicillin for Severe Pneumonia Among Kenyan Children: A Pragmatic Randomized Controlled Noninferiority Trial
por: Agweyu, Ambrose, et al.
Publicado: (2015)

Intravenous Amoxicillin Plus Intravenous Gentamicin for Children with Severe Pneumonia in Bangladesh: An Open-Label, Randomized, Non-Inferiority Controlled Trial
por: Shahrin, Lubaba, et al.
Publicado: (2021)

Co‐trimoxazole prophylaxis for children who are HIV‐exposed and uninfected: a systematic review
por: Wedderburn, Catherine J., et al.
Publicado: (2023)

Co-trimoxazole induced hyperkalemia and potassium monitoring in hospitalized patients
por: Plantaz, Milan M. E. A., et al.
Publicado: (2020)

Genomic identification of a novel co-trimoxazole resistance genotype and its prevalence amongst Streptococcus pneumoniae in Malawi
por: Cornick, Jennifer E., et al.
Publicado: (2014)

Co-trimoxazole versus azithromycin for the treatment of undifferentiated febrile illness in Nepal: study protocol for a randomized controlled trial
por: Pokharel, Sunil, et al.
Publicado: (2017)

Daily co-trimoxazole prophylaxis to prevent mortality in children with complicated severe acute malnutrition: a multicentre, double-blind, randomised placebo-controlled trial
por: Berkley, James A, et al.
Publicado: (2016)

Placebo vs Amoxicillin for Nonsevere Fast-Breathing Pneumonia in Malawian Children Aged 2 to 59 Months: A Double-blind, Randomized Clinical Noninferiority Trial
por: Ginsburg, Amy Sarah, et al.
Publicado: (2018)

Characterisation of rectal amoxicillin (RAMOX) for the treatment of pneumonia in children
por: Hanning, Sara M, et al.
Publicado: (2020)

Resistance gene pool to co-trimoxazole in non-susceptible Nocardia strains
por: Valdezate, Sylvia, et al.
Publicado: (2015)

Acute glycaemic effects of co-trimoxazole at prophylactic dose in healthy adults
por: Kenteu, Bernold, et al.
Publicado: (2016)

Incidence of Co-Trimoxazole-Induced Hyperkalemia in a Tertiary Care Hospital
por: Al AdAwi, Rana M, et al.
Publicado: (2021)

Efficacy and safety of co-trimoxazole in eradication phase of melioidosis; systematic review
por: Keragala, Keragala Arachchige Reshani Kaumada, et al.
Publicado: (2023)

Protective efficacy of co-trimoxazole prophylaxis against malaria in HIV exposed children in rural Uganda: a randomised clinical trial
por: Sandison, Taylor G, et al.
Publicado: (2011)

Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy
por: Crook, Angela M., et al.
Publicado: (2016)

Coumarin anticoagulants and co-trimoxazole: avoid the combination rather than manage the interaction
por: Schalekamp, Tom, et al.
Publicado: (2007)

Co-trimoxazole–Sensitive, Methicillin-Resistant Staphylococcus aureus, Israel, 1988–1997
por: Bishara, Jihad, et al.
Publicado: (2003)

Efficacy of Co-Trimoxazole against Experimental Melioidosis Acquired by Different Routes of Infection
por: Nelson, Michelle, et al.
Publicado: (2022)

Evaluation of Weight-Based Co-trimoxazole Dosing in a Saudi Tertiary Hospital
por: Alshehri, Samah, et al.
Publicado: (2023)

Safety of Daily Co-Trimoxazole in Pregnancy in an Area of Changing Malaria Epidemiology: A Phase 3b Randomized Controlled Clinical Trial
por: Manyando, Christine, et al.
Publicado: (2014)

A Retrospective Study on Amoxicillin Susceptibility in Severe Haemophilus influenzae Pneumonia
por: Danneels, Pierre, et al.
Publicado: (2020)

Minimal Inhibitory Concentration of Ceftazidime and Co-trimoxazole for Stenotrophomonas Maltophilia using E-test
por: Jamali, Firoozeh, et al.
Publicado: (2011)

Co-trimoxazole and prevention of relapses of PR3-ANCA positive vasculitis with pulmonary involvement
por: Zycinska, K, et al.
Publicado: (2009)

Preparation and Evaluation of Rifampicin and Co-trimoxazole-loaded Nanocarrier against Brucella melitensis Infection
por: Bodaghabadi, Narges, et al.
Publicado: (2018)

The role of oral co-trimoxazole in treating Nocardia farcinica keratitis: a case report
por: Sharma, Neharika, et al.
Publicado: (2016)

The role of oral co-trimoxazole in treating Nocardia farcinica keratitis—a case report
por: Sharma, Neharika, et al.
Publicado: (2016)

Quality assessment of selected co-trimoxazole suspension brands marketed in Nairobi County, Kenya
por: Irungu, Beatrice Njeri, et al.
Publicado: (2021)

Injectable Amoxicillin Versus Injectable Ampicillin Plus Gentamicin in the Treatment of Severe Pneumonia in Children Aged 2 to 59 Months: Protocol for an Open-Label Randomized Controlled Trial
por: Shahrin, Lubaba, et al.
Publicado: (2020)

Challenges facing effective implementation of co-trimoxazole prophylaxis in children born to HIV-infected mothers in the public health facilities
por: Kamuhabwa, Appolinary AR, et al.
Publicado: (2015)

Adherence to oral amoxicillin dispersible tablets in children with community-acquired pneumonia enrolled in clinical trials in Malawi
por: Ginsburg, Amy Sarah, et al.
Publicado: (2021)

Role of co-trimoxazole prophylaxis in reducing mortality in HIV infected adults being treated for tuberculosis: randomised clinical trial
por: Nunn, Andrew J, et al.
Publicado: (2008)

Comparison of Cardiac Events Associated With Azithromycin vs Amoxicillin
por: Patel, Haridarshan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_op3puv76ldc4foi18uin3kghte